Skip to main content
. 2016 Jan 29;5(1):e61. doi: 10.1038/cti.2015.40

Figure 1.

Figure 1

Screening of hCMRF-56+ blood-derived DCs (BDCs) to Tenth Human Leukocyte Differentiation Antigen (HLDA10) monclonal antibodies (mAbs). A clinical human anti-human-chimeric IgG4 CMRF-56 was used to identify BDCs in PBMCs cultured for 15 h. In the absence of a Toll-like receptor (TLR) stimulus HLA-DR+ hCMRF-56+ BDC bound to mAb 10-27 (unknown specificity), 10-33 (unknown specificity), 10-69 (CMRF-56), 10-41 (CD245), 10-53 (IL-1RAcP), 10-84 (FDF03), 10-70 (P2X7), 10-71 (CLEC4a) and 10-82 (CMRF-44).